Literature DB >> 19761841

Telemetric analysis to detect febrile responses in mice following vaccination with a live-attenuated virus vaccine.

Shannon S Martin1, Russell R Bakken, Cathleen M Lind, Douglas S Reed, Jessica L Price, Craig A Koeller, Michael D Parker, Mary Kate Hart, Donald L Fine.   

Abstract

Non-human primates (NHP) are considered to be the most appropriate model for predicting how humans will respond to many infectious diseases. Due to ethical and monetary concerns associated with the use of NHP, rodent models that are as predictive of responses likely to be seen in human vaccine recipients are warranted. Using implanted telemetry devices, body temperature and activity were monitored in inbred and outbred mouse strains following administration of the live-attenuated vaccine for Venezuelan equine encephalitis virus (VEEV), V3526. Following analysis of individual mouse data, only outbred mouse strains showed changes in diurnal temperature and activity profiles following vaccination. Similar changes were observed following VEEV challenge of vaccinated outbred mice. From these studies, we conclude, outbred mouse strains implanted with telemeters are a sensitive model for predicting responses in humans following vaccination.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19761841      PMCID： PMC2783281          DOI： 10.1016/j.vaccine.2009.09.013

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  27 in total

1.  Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.

Authors:  M K Hart; K Caswell-Stephan; R Bakken; R Tammariello; W Pratt; N Davis; R E Johnston; J Smith; K Steele
Journal:  Vaccine       Date:  2000-07-01       Impact factor: 3.641

2.  Use of telemetry to record body temperature and activity in mice.

Authors:  J G Clement; P Mills; B Brockway
Journal:  J Pharmacol Methods       Date:  1989-04

3.  Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone.

Authors:  N L Davis; N Powell; G F Greenwald; L V Willis; B J Johnson; J F Smith; R E Johnston
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

4.  Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice.

Authors:  G V Ludwig; M J Turell; P Vogel; J P Kondig; W K Kell; J F Smith; W D Pratt
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

5.  Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice.

Authors:  M K Hart; C Lind; R Bakken; M Robertson; R Tammariello; G V Ludwig
Journal:  Vaccine       Date:  2001-11-12       Impact factor: 3.641

6.  Correlation of body temperature with protection against staphylococcal enterotoxin B exposure and use in determining vaccine dose-schedule.

Authors:  James W Boles; M Louise M Pitt; Ross D LeClaire; Paul H Gibbs; Robert G Ulrich; Sina Bavari
Journal:  Vaccine       Date:  2003-06-20       Impact factor: 3.641

7.  Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine.

Authors:  Jiang-Ning Yang; Jiang-Fan Chen; Bertil B Fredholm
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-13       Impact factor: 4.733

8.  Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models.

Authors:  William D Pratt; Nancy L Davis; Robert E Johnston; Jonathan F Smith
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

9.  Effect of gastrointestinal flora on body temperature of rats and mice.

Authors:  M J Kluger; C A Conn; B Franklin; R Freter; G D Abrams
Journal:  Am J Physiol       Date:  1990-02

10.  The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83.

Authors:  R M Kinney; B J Johnson; J B Welch; K R Tsuchiya; D W Trent
Journal:  Virology       Date:  1989-05       Impact factor: 3.616
View more
  8 in total

1.  Differences in postsurgical recovery of CF1 mice after intraperitoneal implantation of radiotelemetry devices through a midline or flank surgical approach.

Authors:  Mark G Chappell; Craig A Koeller; Shannan I Hall
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-03       Impact factor: 1.232

2.  Novel technique for retroperitoneal implantation of telemetry transmitters for physiologic monitoring in Göttingen minipigs (Sus scrofa domesticus).

Authors:  Scott Willens; David M Cox; Ernest H Braue; Todd M Myers; Matthew D Wegner
Journal:  Comp Med       Date:  2014-12       Impact factor: 0.982

3.  Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.

Authors:  Douglas S Reed; Pamela J Glass; Russell R Bakken; James F Barth; Cathleen M Lind; Luis da Silva; Mary Kate Hart; Jonathan Rayner; Kim Alterson; Max Custer; Jeanne Dudek; Gary Owens; Kurt I Kamrud; Michael D Parker; Jonathan Smith
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

4.  Core body temperature as adjunct to endpoint determination in murine median lethal dose testing of rattlesnake venom.

Authors:  Charles C Cates; James G McCabe; Gregory W Lawson; Marcelo A Couto
Journal:  Comp Med       Date:  2014-12       Impact factor: 0.982

5.  Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.

Authors:  Shannon S Martin; Russell R Bakken; Cathleen M Lind; Patricia Garcia; Erin Jenkins; Pamela J Glass; Michael D Parker; Mary Kate Hart; Donald L Fine
Journal:  Vaccine       Date:  2010-03-01       Impact factor: 3.641

6.  A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV).

Authors:  Donald L Fine; Erin Jenkins; Shannon S Martin; Pamela Glass; Michael D Parker; Brad Grimm
Journal:  J Virol Methods       Date:  2009-11-10       Impact factor: 2.014

7.  The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.

Authors:  Ann R Hunt; Shana Frederickson; Toshiaki Maruyama; John T Roehrig; Carol D Blair
Journal:  PLoS Negl Trop Dis       Date:  2010-07-13

8.  Multiparameter telemetry as a sensitive screening method to detect vaccine reactogenicity in mice.

Authors:  Margarete Arras; Daniel L Glauser; Paulin Jirkof; Andreas Rettich; Benjamin Schade; Paolo Cinelli; Daniel D Pinschewer; Mathias Ackermann
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.